Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.
Clinical trial NCT03363217 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03363217
- Sponsor
- St. Justine's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-16
- Primary completion
- 2027-03-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.